Skip to main content
Log in

Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium

  • Brief Reports
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Barber, G. & Spaeth, G. (1969). The successful treatment of homocystinuria with pyridoxine.Journal of Pediatrics, 75, 463–474.

    Google Scholar 

  • Bendich, A., & Cohen, M. (1990). Vitamin B6 safety issues.Annals of the New York Academy of Science, 585, 321–337.

    Google Scholar 

  • Cohen, M. & Bendich, A. (1986). Safety of pyridoxine—A review of human and animal studies.Toxicology Letters, 34, 129–146.

    Google Scholar 

  • Freeman, B. J., Ritvo, E. R., Yokota, A., & Ritvo, A. (1986). A scale for rating symptoms of patients with the syndrome of autism in real life settings.Journal of the American Academy of Child Psychiatry, 25, 130–136.

    Google Scholar 

  • Gerger, A. & Schaumburg, A. (1984). More on neuropathy from pyridoxine abuse.New England Journal of Medicine, 311, 986–988.

    Google Scholar 

  • Gill, H. S., & Rose, G. A. (1986). Mild metabolic hyperoxaluria and its response to pyridoxine.Urology International, 41, 393–396.

    Google Scholar 

  • Kasdan, M. L., & Janes, C. (1987). Carpal tunnel syndrome and vitamin B6.Plastic and Reconstructive Surgery, 79, 456–466.

    Google Scholar 

  • Lelord, G., Callaway, E. & Much, J. P., (1982). Clinical and biological effects of high doses of Vitamin B6 and magnesium on autistic children.Acta Vitaminology and Enzymology, 4, 27–36.

    Google Scholar 

  • Lelord, G., Much, J. P., Barthélémy, C., Martineau, J. & Garreau, B. (1981). Effects of pyridoxine and magnesium on autistic symptoms—initial observations.Journal of Autism and Developmental Disorders, 11, 219–223.

    Google Scholar 

  • Martineau, J., Barthélémy, C., Chelickine, C., & Lelord, G. (1988). Brief Report: An open middle term study of combined Vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.Journal of Autism and Developmental Disorders, 18, 435–443.

    Google Scholar 

  • Martineau, J., Barthélémy, C., Garreau, B., & Lelord, G. (1985). Vitamin B6, magnesium, and combined B6−Mg: Therapeutic effects of childhood autism.Biological Psychiatry, 20, 467–473.

    Google Scholar 

  • Martineau, J., Barthélémy, C. & Lelord, G. (1986). Long-term effects of combined Vitamin B6-magnesium administration in an autistic child.Biological Psychiatry, 21, 511–519.

    Google Scholar 

  • Martineau, J., Barthélémy, C., Roux, S., Garreau, B., & Lelord, G. (1989). Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behavior.Developmental Medicine and Childhood Neurology, 31, 721–726.

    Google Scholar 

  • Martineau, J., Garreau, B., Barthélémy, C., Callaway, E., & Lelord, G. (1981). Effects of vitamin B6 on average evoked potentials in infantile autism.Biological Psychiatry, 16, 627–635.

    Google Scholar 

  • O'Brien, P. M. S. (1982). The premenstrual syndrome: A review of the present status of therapy.Drugs, 24, 140–161.

    Google Scholar 

  • Pettit, R. E. (1987). Pyridoxine dependency seizures: Report of a case with unusual features.Journal of Childhood Neurology, 2, 38–41.

    Google Scholar 

  • Rimland, B. (1973). High dosage levels of certain vitamins in the treatment of children with severe mental disorders. In D. Hawkins & L. Pauling (Eds.),Orthomolecular psychiatry. San Francisco: W. H. Freeman.

    Google Scholar 

  • Rimland, B., Callaway, E., & Dreyfuss, P. (1978). The effects of high doses of vitamin B6 on autistic children: A double-blind cross-over study.American Journal of Psychiatry, 135, 472–478.

    Google Scholar 

  • Schaumburg, H., Kaplan, J., Windebank, A., Vick, N., Rasmus, S., Pleasure, D., & Brown, M. J. (1983). Sensory neuropathy from pyridoxine.New England Journal of Medicine, 309, 445–447.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The authors thank Ted Butterworth, Tom Vaughan, and Al Bartolucci, as well as the staff of Allan Cott School for their assistance with this project. We also thank Hoffmann LaRoche for the pyridoxine and placebo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tolbert, L., Haigler, T., Waits, M.M. et al. Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord 23, 193–199 (1993). https://doi.org/10.1007/BF01066428

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01066428

Keywords

Navigation